Cargando…
BREAKING GROUND IN TRANSLATIONAL GEROSCIENCE: FROM BIOMARKERS TO CLINICAL TRIALS
The geroscience hypothesis posits that common biological mechanisms of aging drive susceptibility of aged individuals to functional decline, multi-morbidity, and death. The promise of geroscience is that some of these mechanisms may be intervenable, thereby preventing or delaying declines, and provi...
Autor principal: | Justice, Jamie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766170/ http://dx.doi.org/10.1093/geroni/igac059.649 |
Ejemplares similares
-
Operationalizing Healthspan as an Outcome for Clinical Trials in Geroscience
por: Justice, Jamie
Publicado: (2021) -
BIOMARKER STRATEGIES FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019) -
The Translational Geroscience Network: Supporting a New Paradigm to Alleviate Age-Related Chronic Disease
por: Justice, Jamie, et al.
Publicado: (2020) -
The First Evaluation of a Geroscience Biomarker Index (TAME-BI) in a Trial of Caloric Restriction and Exercise
por: Justice, Jamie, et al.
Publicado: (2021) -
Approaching Multimorbidity From a Translational Geroscience Perspective
por: Newman, Anne
Publicado: (2021)